Imaflex Inc.

TSXV:IFX Lagerbericht

Marktkapitalisierung: CA$56.8m

Imaflex Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Imaflex wird voraussichtlich ein Umsatzwachstum verzeichnen 5.5% p.a. sinken.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Packaging Gewinnwachstum13.0%
Wachstumsrate der Einnahmen4.0%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert26 Apr 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Revenues Not Telling The Story For Imaflex Inc. (CVE:IFX) After Shares Rise 48%

Jun 13
Revenues Not Telling The Story For Imaflex Inc. (CVE:IFX) After Shares Rise 48%

There May Be Some Bright Spots In Imaflex's (CVE:IFX) Earnings

Jun 05
There May Be Some Bright Spots In Imaflex's (CVE:IFX) Earnings

Imaflex (CVE:IFX) Might Be Having Difficulty Using Its Capital Effectively

Jan 06
Imaflex (CVE:IFX) Might Be Having Difficulty Using Its Capital Effectively

Is Imaflex (CVE:IFX) A Risky Investment?

Nov 25
Is Imaflex (CVE:IFX) A Risky Investment?

Does Imaflex (CVE:IFX) Deserve A Spot On Your Watchlist?

May 25
Does Imaflex (CVE:IFX) Deserve A Spot On Your Watchlist?

We Think Imaflex (CVE:IFX) Can Stay On Top Of Its Debt

Mar 14
We Think Imaflex (CVE:IFX) Can Stay On Top Of Its Debt

Does Imaflex (CVE:IFX) Have A Healthy Balance Sheet?

Aug 24
Does Imaflex (CVE:IFX) Have A Healthy Balance Sheet?

Is It Too Late To Consider Buying Imaflex Inc. (CVE:IFX)?

May 10
Is It Too Late To Consider Buying Imaflex Inc. (CVE:IFX)?

Imaflex (CVE:IFX) Could Easily Take On More Debt

Oct 23
Imaflex (CVE:IFX) Could Easily Take On More Debt

Investors Should Be Encouraged By Imaflex's (CVE:IFX) Returns On Capital

Sep 04
Investors Should Be Encouraged By Imaflex's (CVE:IFX) Returns On Capital

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imaflex Inc.'s (CVE:IFX) CEO For Now

Jun 10
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imaflex Inc.'s (CVE:IFX) CEO For Now

Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

Jun 03
Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

Here's Why I Think Imaflex (CVE:IFX) Might Deserve Your Attention Today

Apr 19
Here's Why I Think Imaflex (CVE:IFX) Might Deserve Your Attention Today

Imaflex (CVE:IFX) Shareholders Will Want The ROCE Trajectory To Continue

Mar 30
Imaflex (CVE:IFX) Shareholders Will Want The ROCE Trajectory To Continue

Did Imaflex Inc. (CVE:IFX) Insiders Sell Shares?

Mar 01
Did Imaflex Inc. (CVE:IFX) Insiders Sell Shares?

Is Imaflex Inc.'s (CVE:IFX) Latest Stock Performance A Reflection Of Its Financial Health?

Feb 04
Is Imaflex Inc.'s (CVE:IFX) Latest Stock Performance A Reflection Of Its Financial Health?

Is Imaflex (CVE:IFX) A Risky Investment?

Jan 17
Is Imaflex (CVE:IFX) A Risky Investment?

What We Make Of Imaflex's (CVE:IFX) Returns On Capital

Dec 30
What We Make Of Imaflex's (CVE:IFX) Returns On Capital

Imaflex (CVE:IFX) Is Growing Earnings But Are They A Good Guide?

Dec 15
Imaflex (CVE:IFX) Is Growing Earnings But Are They A Good Guide?

Have Insiders Sold Imaflex Inc. (CVE:IFX) Shares Recently?

Nov 30
Have Insiders Sold Imaflex Inc. (CVE:IFX) Shares Recently?

What Does Imaflex's (CVE:IFX) CEO Pay Reveal?

Nov 26
What Does Imaflex's (CVE:IFX) CEO Pay Reveal?

Gewinn- und Umsatzwachstumsprognosen

TSXV:IFX - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CAD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/2025104N/AN/AN/A1
12/31/202497N/AN/AN/A1
3/31/2024981-110N/A
12/31/2023941-85N/A
9/30/2023922-67N/A
6/30/2023965-112N/A
3/31/20231048117N/A
12/31/20221129317N/A
9/30/202211510314N/A
6/30/202211810312N/A
3/31/2022114859N/A
12/31/2021107868N/A
9/30/2021104869N/A
6/30/202197779N/A
3/31/20219151113N/A
12/31/20208761012N/A
9/30/20208351012N/A
6/30/2020804510N/A
3/31/202080439N/A
12/31/2019812410N/A
9/30/201985228N/A
6/30/201987247N/A
3/31/201988213N/A
12/31/2018864-31N/A
9/30/201885402N/A
6/30/2018854-12N/A
3/31/201887415N/A
12/31/2017884N/A3N/A
9/30/2017863N/A2N/A
6/30/2017823N/A4N/A
3/31/2017762N/A2N/A
12/31/2016740N/A4N/A
9/30/2016721N/A2N/A
6/30/2016721N/A2N/A
3/31/2016731N/A1N/A
12/31/2015691N/A0N/A
9/30/2015681N/A2N/A
6/30/2015660N/A-1N/A
3/31/2015620N/A0N/A
12/31/2014610N/A-1N/A
9/30/2014590N/A-1N/A
6/30/201459-1N/A0N/A
3/31/2014580N/A-1N/A
12/31/2013560N/A2N/A
9/30/2013540N/A2N/A
6/30/2013500N/A2N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von IFX über der Sparquote liegt (2.1%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von IFX schneller wachsen werden als der Markt Canadian

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von IFX in den nächsten 3 Jahren signifikant steigen werden.

Einnahmen vs. Markt: IFXDie Einnahmen des Unternehmens (5.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Canadian (6.9% pro Jahr).

Hohe Wachstumseinnahmen: IFXDie Einnahmen des Unternehmens (5.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von IFX in 3 Jahren voraussichtlich hoch sein wird

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y